Dr. Stela Dragomanova| Neuroscience | Best Researcher Award

Dr. Stela Dragomanova, Medical University of Varna, Bulgaria

Dr. Stela Dragomanova is a distinguished researcher and educator at the Medical University of Varna. She earned her master’s degree in Pharmacy from the Medical University of Sofia in 2004 and later specialized in Clinical Pharmacy. In 2020, she completed her Ph.D. in Pharmacology at the Institute of Neurobiology, Bulgarian Academy of Sciences. Dr. Dragomanova’s research centers on neuropharmacology, particularly neurodegenerative diseases. She is a member of the Bulgarian Pharmaceutical Union and serves as Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna. Dr. Dragomanova has published 30+ peer-reviewed papers, contributing significantly to pharmacology and neuroscience. She has also served as Assistant Professor from 2010 to 2021 and is currently Chief Assistant Professor in the Department of Pharmacology at the Medical University of Varna.

Professional Profile

Orcid

Summary of Suitability for the Research for Best Researcher Award

Dr. Stela Dragomanova demonstrates a strong profile as a candidate for the Research for Best Researcher Award. With a Ph.D. in Pharmacology and a focus on neuropharmacology, her research is centered around neurodegenerative diseases, a critical area of biomedical research. Her expertise in in vivo preclinical models and behavioral tests positions her as a valuable contributor to the scientific community, particularly in neuropharmacology and toxicology.Her academic career includes over a decade of teaching and research at the Medical University of Varna, Bulgaria, where she has steadily advanced from Assistant Professor to Chief Assistant Professor. Dr. Dragomanova has also made substantial contributions to the scientific literature, with 30+ publications, including articles in high-impact journals such as Antioxidants and Molecules, with topics addressing neuroprotective strategies and experimental pharmacology.

Education

Dr. Stela Dragomanova began her academic journey at the Medical University of Sofia, where she obtained her master’s degree in Pharmacy in 2004. She further specialized in Clinical Pharmacy, enhancing her expertise in pharmacological interventions. Driven by her passion for neuropharmacology, Dr. Dragomanova pursued her Ph.D. in Pharmacology at the Bulgarian Academy of Sciences’ Institute of Neurobiology, completing it in 2020. Her doctoral research provided significant insights into neurodegenerative diseases and related pharmacotherapies. With a strong foundation in experimental pharmacology and toxicology, Dr. Dragomanova is equipped with advanced skills in preclinical in vivo models and behavioral testing. Her academic qualifications, coupled with her research experience, reflect her commitment to advancing knowledge in the pharmaceutical and neuropharmacological fields.

Experience

Dr. Stela Dragomanova has been an integral part of the Medical University of Varna since 2010, starting as an Assistant Professor in the Department of Pharmacology, Toxicology, and Pharmacotherapy. She transitioned into the role of Chief Assistant Professor in 2021, where she continues to lead and mentor young scientists in neuropharmacology. In her academic career, she has overseen numerous research projects focusing on neurodegenerative disorders, particularly in exploring neuroprotective agents and pharmacological treatments. She has extensive expertise in in vivo preclinical models and behavioral testing in experimental pharmacology. Dr. Dragomanova is also deeply involved in regulatory and ethical aspects of pharmacology research, serving as the Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna and being an active member of several scientific and pharmaceutical associations.

Awards and Honors

Dr. Stela Dragomanova has been recognized for her outstanding contributions to the field of pharmacology and her dedication to healthcare and education. In 2018, she was named “Pharmacist of the Year” for the Varna region by the Regional Pharmaceutical Collegium. This prestigious award highlights her commitment to the pharmaceutical profession and the positive impact of her work in the healthcare sector. In addition to her regional recognition, Dr. Dragomanova is an esteemed member of the Bulgarian Pharmaceutical Union, which is part of the Pharmaceutical Group of the European Union (PGEU). She also holds leadership roles in several academic and professional organizations, including the Bulgarian Association of Pharmacology, Clinical Pharmacology, and Therapeutics. Her extensive experience in both research and education further solidifies her as a prominent figure in the pharmacological sciences.

Research Focus

Dr. Stela Dragomanova’s research is primarily focused on neuropharmacology, particularly in understanding the mechanisms underlying neurodegenerative diseases. Her work aims to discover potential therapeutic agents that can mitigate the progression of disorders such as Alzheimer’s and Parkinson’s disease. She has developed expertise in using in vivo preclinical models to evaluate neuroprotective compounds and conduct behavioral tests. Her research explores the role of antioxidants and polyphenols, studying their neuroprotective effects and potential applications in pharmacotherapy. Additionally, Dr. Dragomanova is interested in the therapeutic potential of lipid emulsions in treating convulsions and other toxicological conditions. Her investigations have led to a deeper understanding of the molecular and biochemical processes that drive neurodegeneration, with a strong focus on developing novel interventions for these challenging medical conditions.

Publications Top Notes

Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
Trehalose: Neuroprotective Effects and Mechanisms—An Updated Review
Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
Neuropharmacological investigation of myrtenal conjugates with aminoadamantane
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2

David Monroy, University of Miami, United States

David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.

Professional Profile

orcid

Education :

David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.

Experience :

David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.

Awards and Honors :

David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.

Research Focus :

David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.

Publication Top notes :

📘 Alvarez OP., Monroy D., Thura S., et al. Infectious Etiology of Conjunctival Tumors. Expert Review of Ophthalmology, 2024.
👁️ Monroy D., Venkateswaran N., Matthews JL., et al. Conjunctival keratoacanthoma: a clinical and histopathological case series. Canadian Journal of Ophthalmology, 2024.
🔬 Monroy D., Serrano A., Galor A., & Karp CL. Medical treatments for ocular surface squamous neoplasia. Eye, 2023.
💀 Monroy D., Garcia J., Zarate SD., et al. Displaced humeral pathological fracture secondary to intraosseous hemangioma. Radiology Case Reports, 2022.